These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 9259175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG, Cold JA, Jann MW.
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic interactions of antidepressants.
    Richelson E.
    J Clin Psychiatry; 1998; 59 Suppl 10():22-6. PubMed ID: 9720479
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nefazodone and venlafaxine: two new agents for the treatment of depression.
    Goldberg RJ.
    J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B, Benfield P.
    Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
    Owen JR, Nemeroff CB.
    Depress Anxiety; 1998 Sep; 7 Suppl 1():24-32. PubMed ID: 9597349
    [Abstract] [Full Text] [Related]

  • 13. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 Sep; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 14. Clinical overview on moclobemide.
    Tiller JW.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):703-12. PubMed ID: 8255982
    [Abstract] [Full Text] [Related]

  • 15. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Sep; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 16. Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients.
    Nair NP, Ahmed SK, Kin NM, West TE.
    Acta Psychiatr Scand Suppl; 1995 Sep; 386():28-35. PubMed ID: 7717092
    [Abstract] [Full Text] [Related]

  • 17. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 18. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR, Burrows GD.
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [Abstract] [Full Text] [Related]

  • 19. [Two new antidepressants: mirtazapine and venlafaxine].
    Birkenhäger TK, Moleman P.
    Ned Tijdschr Geneeskd; 1999 May 01; 143(18):934-7. PubMed ID: 10368708
    [Abstract] [Full Text] [Related]

  • 20. Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
    Möller HJ, Volz HP.
    Drugs; 1996 Nov 01; 52(5):625-38. PubMed ID: 9118813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.